ReviewChinese medical journal pulmonary and critical care medicine2025

Sphingolipid metabolism dysregulation: A cause for lung cancer development, progression, and resistance to therapies.

Cungui MaoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.